Company Overview
| Stock Name | Sihuan Pharm |
|---|---|
| Stock Code | 00460 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們是一家領先的醫藥公司,主要從事心腦血管藥物、抗感染藥物及其他藥物的生產與銷售,並擁有覆蓋全國31個省市及自治區近10,000家醫院的分銷網絡。 |
| Listing Date | 2010-10-28 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港灣仔港灣道1號會展廣場辦公大樓4905室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | sihuanpharm.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 4.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.01 / shares |
| Offer Period | 2010-10-20 to 2010-10-20 |
| Global Offering Shares | 1,250,000,000 shares |
| HK Public Offer Shares (Initial) | 125,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 1,125,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 5,000,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 27.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 5,750,000,000 |
Stock Connect Inclusion Analysis
| Avg Daily HK Mkt Cap | HK$ 9.29B |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣313.7百萬元 |
| Period-End Cash Balance | 人民幣612.9百萬元 |
| Listing Expenses | ~HK$ 229,000,000 |
| Listing Expenses / Funds Raised | ~3.98% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2007 | 2008 | 2009 | 2010-06 |
|---|---|---|---|---|
| Revenue | 286,349 | 510,048 | 708,907 | 473,437 |
| Cost of sales | -60,526 | -133,551 | -191,915 | -127,074 |
| Gross profit | 225,823 | 376,497 | 516,992 | 346,363 |
| Other income and gains, net | 22,744 | -8,014 | -16,348 | 19,444 |
| Selling and distribution expenses | -22,732 | -38,906 | -48,810 | -26,364 |
| Administrative expenses | -38,856 | -53,405 | -78,809 | -52,420 |
| Operating profit | 186,979 | 276,172 | 373,025 | 287,023 |
| Net finance costs | -2,527 | 470 | 5,644 | 3,072 |
| Share of associates and JVs | 0 | 10,427 | 2,357 | 0 |
| Profit before tax | 184,452 | 287,069 | 381,026 | 290,095 |
| Income tax expense | -5,626 | -53,621 | -67,370 | -42,683 |
| Profit for the year | 178,826 | 233,448 | 313,656 | 247,412 |
| Profit attributable to owners | 179,266 | 237,059 | 326,316 | 254,849 |
Balance Sheet
| Item | 2007 | 2008 | 2009 | 2010-06 |
|---|---|---|---|---|
| Cash and cash equivalents | 262,380 | 331,178 | 612,859 | 620,378 |
| Trade and bills receivables | 24,714 | 71,424 | 141,132 | 310,519 |
| Inventories | 22,953 | 39,395 | 42,967 | 49,298 |
| Total current assets | 310,047 | 441,997 | 796,958 | 980,195 |
| Total assets | 630,546 | 862,051 | 1,173,442 | 1,363,355 |
| Total current liabilities | 95,519 | 127,194 | 219,260 | 179,924 |
| Total liabilities | 105,733 | 146,191 | 249,255 | 190,685 |
| Total equity | 524,813 | 715,860 | 924,187 | 1,172,670 |
| Equity attributable to owners | 524,813 | 701,216 | 907,503 | 1,162,352 |
| Interest-bearing borrowings | 12,000 | 0 | 0 | 0 |
Cash Flow Statement
| Item | 2007 | 2008 | 2009 | 2010-06 |
|---|---|---|---|---|
| Net cash from operating activities | 182,565 | 256,819 | 385,648 | 183,984 |
| Net cash from investing activities | -155,731 | -115,365 | 16,062 | -2,526 |
| Net cash from financing activities | 193,758 | -72,656 | -120,029 | -173,939 |
| Net increase in cash | 220,592 | 68,798 | 281,681 | 7,519 |
| Purchase of PP&E | -30,839 | -29,452 | -56,677 | -18,580 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 5.77 |
|---|---|
| First Day Open | HK$ 6.05 |
| First Day Change | 25.43% |
| First Day Volume | 804820000.0 |
| First Day Turnover | 4724570000.0 |
| Use of Proceeds | 1、約20%或1101.0百萬港元,將用于研發:
a.約10%或550.5百萬港元,將用于撥付我們的產品開 發及研究;
b.約10%或550.5百萬港元,將用于開發我們現有的候 選產品
2、約15%或825.7百萬港元,將用于收購能補充及擴展我們現有產品組合的特定產品或生產線;
3、約15%或825.7百萬港元,將用于向建設位于廊坊及北京的兩項新生產設施所需的資本開支提供資金;
4、約30%或1651.4百萬港元,將用于我們發現適當的目標公司或業務進行上述活動時可能產生的并購機會;
5、約10%或550.5百萬港元,將用于加大銷售及分銷力度;
6、約10%或550.5百萬港元,將用作營運資金及一般公司開支。 |
Underwriting Syndicate
Overall Coordinators (2)
Joint Bookrunners (2)
Joint Lead Managers (3)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Gaoling Fund, L.P. | 378,718,000 HKD | — | 6.60% | — | 6 months | 2011-04-28 |
| 2 | Quantum Partners LP | 336,637,200 HKD | — | 5.90% | — | 6 months | 2011-04-28 |
| 3 | 惠理基金管理香港有限公司 | 168,318,600 HKD | — | 2.90% | — | 6 months | 2011-04-28 |
| 4 | 建银国际资产管理有限公司 | 126,237,800 HKD | — | 2.20% | — | 6 months | 2011-04-28 |
| 5 | 云峰基金 | 168,318,600 HKD | — | 2.90% | — | 6 months | 2011-04-28 |
| 6 | 中国人寿保险(海外)股份有限公司 | 168,318,600 HKD | — | 2.90% | — | 6 months | 2011-04-28 |
| 7 | 中国人寿保险(集团)公司 | 252,480,200 HKD | — | 4.40% | — | 6 months | 2011-04-28 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 車馮升 | — |
| Company Secretary | 陳燕玲,李健威 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 控股股東為Plenty Gold及車醫生。緊隨全球發售後(不計超額配股權),Plenty Gold持有約65.8%權益,車醫生持有約67.0%權益(包括其於Plenty Gold的51%實益權益及直接持股)。 |
|---|




